Directorate-General for Research & Innovation logo Horizon: the EU Research & Innovation magazine | European Commission logo
Receive our editor’s picks

Catching up with CRISPR

CRISPR-Cas9 is a versatile gene editing system that exploits the way that bacterial immune systems defend against viruses. Image credit - Flickr/ NIH Image Gallery, image is in the public domain

Seven years after scientists successfully managed to adapt a gene editing system used by bacteria into one that can be easily used in labs to edit human genes, we take a look at some of the emerging applications and ethical issues of CRISPR-Cas9. We talk to the head of the European Group on Ethics in Science and New Technologies about whether the simplicity and low cost of CRISPR means that there is potential for misuse and what should be done about this. We find out how scientists have used CRISPR to create cows lacking two sugars that trigger the human immune system, leading to hopes of longer-lasting heart valves for transplant patients and healthier red meat. And we speak to researchers who are using CRISPR to improve other gene editing technologies.